Form 4: Elanco EVP Sells Shares for Tax Obligations

Elanco Animal Health's EVP of Manufacturing and Quality, Grace McArdle, sold 4,322 shares of common stock to cover tax liabilities.

Summary

• Grace McArdle, Executive Vice President of Manufacturing and Quality at Elanco Animal Health Inc., disposed of 4,322 shares of common stock.
• The transaction occurred on March 3, 2026, at a price of $24.88 per share.
• This disposition was made to satisfy tax withholding obligations related to the vesting of equity awards.
• Following this transaction, Ms. McArdle beneficially owns 103,705 shares of Elanco Animal Health Inc. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the disposition of shares is a routine, non-discretionary transaction to cover tax obligations related to executive compensation, rather than a discretionary sale based on market outlook.

Industry Context

StockSavvy.ai notes that routine insider sales for tax purposes, such as those related to equity award vesting, are common across all industries and typically do not reflect a change in management's confidence in the company's long-term prospects. These transactions are often pre-scheduled under Rule 10b5-1 plans.

Related Party Transactions

• Grace McArdle, an Executive Vice President of Elanco Animal Health Inc., disposed of company common stock, which constitutes an insider transaction.

Stakeholder Impact

• Shareholders: The sale of a relatively small number of shares by an executive for tax purposes is unlikely to have a material impact on the overall shareholder base or stock valuation.
• Employees: No direct impact on employees is indicated by this routine transaction.
• Management: The transaction reflects a standard part of executive compensation, where equity awards vest and associated tax obligations are met.

Key Dates

Keywords

Elanco Animal Health, ELAN, Insider Transaction, Form 4, Stock Sale, Executive Compensation, Grace McArdle, Tax Withholding